3.5.1.92	diagnostics	enzyme Vnn1 is a valid biomarker for aggressive soft tissue sarcomas (STS) prognosis	757538	
3.5.1.92	diagnostics	potential use of vanin-1 as a marker of severity and therapeutic target in systemic sclerosis (SSc)	-, 757352	
3.5.1.92	diagnostics	usefulness of urinary vanin-1 with other biomarkers for the detection of renal complications in rats with experimental colitis	-, 734049	
3.5.1.92	diagnostics	vanin-1 is a biomarker of nephrotoxicant-induced kidney injury, increase in urinary vanin-1 is detected before the elevations of serum creatinine or urinary N-acetyl-beta-glucosaminidase, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin, in models of drug-induced acute kidney injury, overview	-, 734537	
3.5.1.92	drug development	the highly sensitive fluorescent assay for the hydrolysis of pantothenate-7-amido-4-methylcoumarin as substrate to pantothenic acid and 7-amino-4-methylcoumarin could be a powerful tool for target validation and drug lead identification and characterization	710847	
3.5.1.92	medicine	manipulation the Vanin-1/pantetheinase activity represents an attractive therapeutic strategy for the treatment of inflammatory bowel disease	688102	
3.5.1.92	medicine	the pantetheinase activity of vanin-1 molecule could be a target for a new anti-inflammatory strategy	659573	
3.5.1.92	medicine	vanin-1 is a potential biomarker for nephrotoxicant-induced renal injury	721078